Intravenous isoproterenol as a marker for epidural test-dosing in children.

The purpose of this study was to determine if isoproterenol would be an effective marker of intravascular injection in anesthetized children. Forty-four ASA 1 children, aged 2 mo to 10 yr, were randomly assigned to two groups. Children in group 1 (n = 21) received 0.05 microgram/kg isoproterenol, and children in group 2 (n = 23) received 0.075 microgram/kg isoproterenol. A blinded observer continuously recorded heart rate and arterial blood pressure. Measurements were recorded before the surgical incision at steady-state halothane concentration of 1.2 minimum alveolar concentration adjusted for age. Isoproterenol produced a graded increase in heart rate with mean maximum increases of 16.5 +/- 8.7 beats/min in group 1 and 21.5 +/- 9.2 beats/min in group 2. No episodes of hypotension and arrhythmia were noted. Isoproterenol, 0.075 microgram/kg, is more sensitive but still is an imperfect marker of an intravascular injection. It produces a heart rate increase in 96% of children anesthetized with halothane and nitrous oxide in 50% oxygen. The application of isoproterenol as an epidural test dose appears promising, but cannot be recommended until its full reliability and neurotoxicity are evaluated.

RCT Entities:   Population Interventions Outcomes